Stem cells in human neurodegenerative disorders — time for clinical translation?
Top Cited Papers
Open Access
- 4 January 2010
- journal article
- review article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 120 (1), 29-40
- https://doi.org/10.1172/jci40543
Abstract
Stem cell–based approaches have received much hype as potential treatments for neurodegenerative disorders. Indeed, transplantation of stem cells or their derivatives in animal models of neurodegenerative diseases can improve function by replacing the lost neurons and glial cells and by mediating remyelination, trophic actions, and modulation of inflammation. Endogenous neural stem cells are also potential therapeutic targets because they produce neurons and glial cells in response to injury and could be affected by the degenerative process. As we discuss here, however, significant hurdles remain before these findings can be responsibly translated to novel therapies. In particular, we need to better understand the mechanisms of action of stem cells after transplantation and learn how to control stem cell proliferation, survival, migration, and differentiation in the pathological environment.This publication has 148 references indexed in Scilit:
- Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinicThe Lancet Neurology, 2009
- Stem cell‐based cell therapy in neurological diseases: A reviewJournal of Neuroscience Research, 2009
- Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming FactorsCell, 2009
- Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: Differentiation and structural integration into the segmental motor circuitryJournal of Comparative Neurology, 2009
- Generation of spinal motor neurons from human fetal brain‐derived neural stem cells: Role of basic fibroblast growth factorJournal of Neuroscience Research, 2008
- Disease-Specific Induced Pluripotent Stem CellsCell, 2008
- Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer’s disease-like transgenic (pPDGF-APPSw,Ind) miceNeurobiology of Disease, 2008
- Intravenous administration of glial cell line‐derived neurotrophic factor gene‐modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult ratJournal of Neuroscience Research, 2006
- Identification of Intrinsic Determinants of Midbrain Dopamine NeuronsCell, 2006
- Directed Differentiation of Embryonic Stem Cells into Motor NeuronsCell, 2002